Core Scientific Announces Second Quarter 2026 Financial Results

Timing and Content of the Second Quarter Announcement

Core Scientific released its Q2 2026 financial results on July 28, 2026, through a formal current report filing with the Securities and Exchange Commission. The announcement occurred approximately one month after the close of the second fiscal quarter on June 30, 2026. The disclosure structure included both a press release and a company presentation, furnishing investors with comprehensive information regarding the company's operational and financial performance during this period.

The current report, filed under Item 2.02 Results of Operations and Financial Condition, represents the company's standard quarterly earnings announcement mechanism. By selecting this disclosure vehicle, Core Scientific provided market participants with timely access to results while maintaining regulatory compliance with federal securities law requirements for public companies traded on NASDAQ.

Multi-Class Security Structure and NASDAQ Trading

Core Scientific maintains a complex capital structure reflected in its multiple securities traded on NASDAQ. The company has three distinct publicly traded security classes: common stock trading under the symbol CORZ, warrants exercisable at $6.81 per share trading as CORZW, and warrants exercisable at $0.01 per share trading as CORZZ. This multi-tiered structure provides investors with varied exposure mechanisms to the underlying business and is typical of companies that have undergone significant corporate reorganizations or financing activities.

The warrant structures at materially different exercise prices suggest Core Scientific completed financing activities at different valuation points in its corporate history. Warrant holders possess contractual rights to purchase shares of common stock at their respective exercise prices, creating leverage for investors betting on upside share price appreciation. The presence of warrants with nominal $0.01 exercise prices indicates these securities may have originated from equity financing during an earlier period when the company's valuation was substantially lower.

Delaware Incorporation and Regulatory Compliance Status

Core Scientific, Inc. is incorporated in Delaware and maintains its principal executive offices in Dover, Delaware. The company holds Commission File Number 001-40046 and an IRS Employer Identification Number of 86-1243837. Delaware incorporation is standard practice among large publicly traded companies due to the state's well-developed corporate law framework and specialized Court of Chancery, which provides predictability in corporate governance matters.

In its current report, Core Scientific confirmed it does not qualify as an emerging growth company under Securities Act Rule 405 or Exchange Act Rule 12b-2 definitions. This determination means the company must comply with all standard financial reporting requirements applicable to mature public companies without access to extended transition periods for new accounting standards. The company's non-emerging growth status reflects its market maturity and the extent of its public float.

Press Release and Presentation Materials as Formal Disclosure

The current report specifically incorporates by reference a press release dated July 28, 2026, and a company presentation dated the same date, both filed as exhibits to the form. These materials contain the substantive financial and operational information regarding Core Scientific's second quarter 2026 performance. The filing mechanism ensures that market-moving information reaches all investors simultaneously through SEC Edgar rather than through selective media or analyst briefings.

Investors seeking detailed financial metrics, management commentary on business conditions, operational highlights, or forward-looking statements should review the attached press release and presentation materials, as the current report itself does not recite specific financial figures. This layered disclosure approach is standard regulatory practice, allowing the current report to serve as the official filing vehicle while the exhibits provide granular performance data.

Regulation FD Disclosure Framework

Core Scientific invoked Item 7.01 (Regulation FD Disclosure) in addition to Item 2.02 Results of Operations and Financial Condition. Regulation Fair Disclosure requires that material information be disseminated to all investors simultaneously rather than selectively shared. By filing the earnings announcement through an 8-K form incorporating Regulation FD procedures, Core Scientific ensures no investor receives preferential early access to quarterly results.

The company's filing explicitly states that the information in Items 2.02 and 7.01, including all exhibits, is furnished rather than filed. This distinction means the furnishing investor information is not automatically incorporated by reference into other Securities Act filings the company may make. This technical designation provides some regulatory clarity regarding the treatment of earnings announcements in the company's broader disclosure obligations.

Chief Legal Officer Certification and Management Authority

Todd M. DuChene, serving as Chief Legal Officer and Chief Administrative Officer, executed the current report on behalf of Core Scientific. Dual role responsibility for legal and administrative functions often indicates a leaner corporate governance structure, with consolidation of certain executive functions. DuChene's signature on the form certifies that Core Scientific completed the filing in accordance with Securities Exchange Act Section 13 or 15(d) requirements.

The officer signature requirement ensures corporate accountability for the accuracy and timeliness of regulatory filings. Executive officers bear personal responsibility for ensuring disclosures comply with applicable securities regulations and reflect the company's true financial and operational condition. This certification mechanism represents a key component of the post-Sarbanes-Oxley regulatory framework designed to enhance financial reporting integrity.

Mining and Infrastructure Industry Context

Core Scientific operates in the cryptocurrency mining sector, a business segment that has experienced significant volatility in valuations, regulatory treatment, and operational profitability. The company's multi-warrant structure and complex capital history reflect the sector's dynamic fundraising environment. Mining operations are capital-intensive, require reliable energy supply, and generate returns closely tied to cryptocurrency market prices and network difficulty adjustments.

The disclosure of Q2 2026 results provides investors with data points regarding how Core Scientific's operations performed during a specific period in the cryptocurrency market cycle. Cryptocurrency mining companies face exposure to factors including bitcoin and other digital asset prices, electricity costs, mining hardware efficiency, and regulatory developments affecting the industry. Investors analyzing Core Scientific should consider these sector-specific dynamics when evaluating the company's financial performance and future prospects.

Interactive Data Filing and Transparency Requirements

Core Scientific submitted Inline XBRL (eXtensible Business Reporting Language) interactive data files as Exhibit 104, embedded within the form's data package. XBRL formatting enables automated parsing of financial information by market data providers, analytical platforms, and institutional investors. This standardized data structure enhances accessibility and analysis of reported financial metrics across large numbers of public companies.

The interactive data filing reflects SEC requirements that public companies file structured financial statement data in machine-readable format. This modernization of disclosure infrastructure supports more efficient capital market functioning by enabling rapid aggregation and comparison of financial metrics across companies. Investors and analysts can programmatically extract and analyze Core Scientific's reported figures rather than manually transcribing data from PDF-formatted documents.

What the Filing Does Not Disclose

The current report itself does not contain specific revenue figures, earnings per share, net income or loss, balance sheet metrics, cash flow information, or detailed operational statistics for the second quarter 2026. These material financial metrics are contained in the attached press release and company presentation rather than in the body of the form. Investors should review the exhibit materials to obtain quantitative performance data.

Similarly, the filing does not include forward-looking statements, management guidance for future quarters, discussion of risks and uncertainties, or detailed analysis of operational results. Management commentary addressing business conditions, competitive developments, and company strategy are typically included in earnings press releases rather than current reports. The current report functions primarily as the regulatory filing vehicle to ensure timely public disclosure of the earnings announcement.